scholarly journals MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cells

2021 ◽  
Vol 24 (2) ◽  
Author(s):  
Xiaoqi Zeng ◽  
Shanshan Jiang ◽  
Simin Ruan ◽  
Zhaoze Guo ◽  
Jingyun Guo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative

scholarly journals Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells

2020 ◽  
Vol 19 (11) ◽  
pp. 1580-1589
Author(s):  
Arghavan Yousefi Sadeghloo ◽  
Khatereh Khorsandi ◽  
Zahra Kianmehr
Keyword(s):  
Breast Cancer ◽  
Combination Therapy ◽  
Synergistic Effect ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Breast Cancer Treatment ◽  
Photodynamic Treatment ◽  
Potential Strategy

Combination therapy of DOX and MB-PDT has a significant synergistic effect on MDA-MB-231 breast cancer cells, which can be considered as a potential strategy for breast cancer treatment.

MiRNAs-181a/b as Predictive biomarkers for olaparib sensitivity in triple-negative breast cancer cells.

2017 ◽  
Vol 12 (1) ◽  
pp. 221-229
Author(s):  
Abeer M. Ashmawy ◽  
Mona A. Sheta ◽  
Faten Zahran ◽  
Abdel Hady A. Abdel Wahab
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Predictive Biomarkers

microRNA-506-3p suppresses the proliferation of triple negative breast cancer cells via targeting SNAI2

2021 ◽  
Vol 17 (4) ◽  
pp. 513-522
Author(s):  
Xuye Zhao ◽  
Xiangdong Bai ◽  
Weina Li ◽  
Xuezhen Gao ◽  
Xiaoli Wang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative
Sign in / Sign up

Export Citation Format

Share Document